novembre 18, 2024 - novembre 19, 2024
/ Global
Date: 18-19 November, 2024
Location: DoubleTree Suites by Hilton Hotel Boston - Cambridge, Boston, Massachusetts, USA
Language: English
Introduction
Medical device manufacturers are confronted with critical challenges, including patient safety, regulatory compliance, and risk management. Discover how to effectively navigate both pre-market and post-market hurdles, ensuring patient safety and regulatory adherence. The Medical Device Biocompatibility USA 2024 is an exhibition and conference where industry leaders gather to explore the latest advancements in medical device biocompatibility and clinical trial regulations.
Join Gert Bos on November 18th for the session ''STRATEGIC APPROACH TO PMS BUILDING ON YOUR RISK MANAGEMENT AND BIOCOMP, TOXICITY, AND CLINICAL DATAS.'' This session will cover strategies for integrating Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) activities to align seamlessly with pre-market evidence. The focus will be on enhancing feedback loops from PMS to improve risk management, clinical evidence, and toxicity assessments. Attendees will learn how to create a comprehensive view of the long-term safety profile of their products, ultimately boosting confidence in their market presence.
For more information about the event and to register, visit the event website.
Qserve Attendee